XENE ▼ -25.4% - Xenon Pharmaceuticals Inc.
$XENE d/g Hold # DB pt 46
Xenon Pharmaceuticals fell 25.4% today following a downgrade to Hold and a price target of $46 from Deutsche Bank, suggesting analyst reassessment of the stock's near-term prospects.
18-SEP-2026 05:20 AM ET
Share this post
More filings for $XENE
XENE ▼ -15.4% - Xenon Pharmaceuticals Inc.Sep 17, 2026XENE ▲ +0.1% - Xenon Pharmaceuticals Inc.Sep 3, 2026XENE ▼ -3.1% - Xenon Pharmaceuticals Inc.Aug 28, 2026XENE - Xenon Pharmaceuticals Inc. - SEC Filing Update (13-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 13, 2026XENE - Xenon Pharmaceuticals Inc. - SEC Filing Update (07-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 7, 2026XENE - Xenon Pharmaceuticals Inc. - SEC Filing Update (06-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 6, 2026
View full $XENE filing history →💬 Comments
Loading comments…
Leave a comment